Mind CBD Fleurs CBD 2 Grammes Lemon Haze (Outdoor) - CBD 12,6%
CBD flower grown in France
Cheap CBD flower in sachets
Certificate of Analysis Flower CBD

Lemon Haze (Outdoor) - CBD 12,6%

Grown outdoors in France and hand-harvested, Lemon Haze wins you over with its lemony, very fruity scent. A Sativa-dominant hybrid with 12.6% CBD, it will delight fans of zesty notes.
Regular price 11,80 € Sale price instead of 20,00 €

Availability: In stock – Ships within 24h

5,90 €/g
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

Lemon Haze CBD Flower, grown in France

  • Grown outdoors in France (Outdoor)
  • Lemony, very fruity flavour
  • CBD 12.6%
  • Sativa-dominant hybrid
  • Hand-harvested

See all products:

Details

Lemon Haze CBD Flower, grown in France

Lemon Haze CBD flower, with a great, very pronounced fruity taste. Grown in France, in the Beaujolais region, by a team of passionate and highly experienced growers.

Cultivation method
Grown in fields in France and hand-harvested.

Species
Sativa-dominant hybrid.

Concentration
CBD: 12.57%
THC: 0.18%

Certification
Product grown outdoors in the Beaujolais, then certified by a GMP-approved laboratory. You will find the certificate of analysis for this product among the photos on this page.

Legislation
This variety, 100% legal in the EU, is a hybrid derived from varieties authorised in the European catalogue.

*Photos are non-contractual, taken by us and from the harvests currently on sale*

Flavours

Lemon Haze CBD Flower (Outdoor) 12.6%

  • Lemony
  • Fruity
  • Minty

Similar products

Discover other Outdoor CBD flowers:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. MILDECA (2021). L'indispensable sur... le cannabidiol (CBD). MILDECA — drogues.gouv.fr. View the source
  2. MILDECA (2023). Le CBD. drogues.gouv.fr (Mission interministérielle de lutte contre les drogues et les conduites addictives). View the source
  3. Chevallier C, Charuel L, Richeval C, Chaouachi L, Del Valle L, Eiden C, Gaulier JM, Batisse A (CEIP-A Paris, Lyon, Montpellier ; CHU Lille) (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source
  4. Dryburgh LM, Bolan NS, Grof CPL, et al. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. View the source

Recently viewed